Ranbaxy to pay $40 million to settle Texas probe on drug pricing

Mint 2018-02-16

Views 0

Ranbaxy has settled the charges with the state authority with a payment of around $40 million. The Texas investigation was related to the manner in which Ranbaxy has historically reported pricing data to Texas Medicaid for certain drugs.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Ranbaxy accused of gaming FDA rules to thwart rival drug makers
play
01:17

Ranbaxy accused of gaming FDA rules to thwart rival drug makers
Reporter's Notebook | Financial impact of the new drug pricing policy
play
01:04

Reporter's Notebook | Financial impact of the new drug pricing policy
China fines Mercedes $56 5 million for price fixing
play
01:21

China fines Mercedes $56 5 million for price fixing
Transformation Agenda 2020 by Mint and Danfoss : India's climate imperatives
play
00:00

Transformation Agenda 2020 by Mint and Danfoss : India's climate imperatives
Transformation Agenda 2020 : Farm to Fork - Challenges and Opportunities for India
play
00:00

Transformation Agenda 2020 : Farm to Fork - Challenges and Opportunities for India
Digitalist Forum with MINT & SAP
play
00:00

Digitalist Forum with MINT & SAP
Transformation Agenda 2020 : India's changing urban landscape
play
00:00

Transformation Agenda 2020 : India's changing urban landscape
Interview: Manipur's, Chief Electoral Officer, P.C. Lawkunga
play
03:14

Interview: Manipur's, Chief Electoral Officer, P.C. Lawkunga
Closing Bell
play
02:23

Closing Bell
Deals Space
play
03:09

Deals Space
Trump meets Singapore PM ahead of historic Summit with Kim Jong Un
play
01:28

Trump meets Singapore PM ahead of historic Summit with Kim Jong Un
The rise, fall and return of Jagmohan Dalmiya
play
01:41

The rise, fall and return of Jagmohan Dalmiya